VeriSign, Inc.
VeriSign, Inc. (VRSN) Financial Performance & Income Statement Overview
Access detailed quarterly and annual financial reports for VeriSign, Inc. (VRSN), covering cash flow, earnings, and balance sheets.
VeriSign, Inc. (VRSN) Income Statement & Financial Overview
Access detailed annual and quarterly income data for VeriSign, Inc. VRSN financial performance.
| Metric | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 |
|---|---|---|---|---|
| Revenue | $402.30M | $395.40M | $390.60M | $387.10M |
| Cost of Revenue | $49.40M | $48.40M | $46.80M | $47.10M |
| Gross Profit | $352.90M | $347.00M | $343.80M | $340.00M |
| Gross Profit Ratio | $0.88 | $0.88 | $0.88 | $0.88 |
| R&D Expenses | $26.00M | $24.90M | $23.20M | $23.80M |
| SG&A Expenses | $55.70M | $58.30M | $51.30M | $50.00M |
| Operating Expenses | $81.70M | $83.20M | $74.50M | $73.80M |
| Total Costs & Expenses | $131.10M | $131.60M | $121.30M | $120.90M |
| Interest Income | $7.90M | $7.00M | $8.70M | $9.70M |
| Interest Expense | $20.30M | $18.80M | $18.90M | $18.80M |
| Depreciation & Amortization | $8.90M | $8.80M | $9.00M | $9.30M |
| EBITDA | $287.60M | $275.70M | $288.80M | $287.00M |
| EBITDA Ratio | $0.71 | $0.70 | $0.74 | $0.74 |
| Operating Income | $271.20M | $263.80M | $269.30M | $266.20M |
| Operating Income Ratio | $0.67 | $0.67 | $0.69 | $0.69 |
| Other Income/Expenses (Net) | -$12.80M | -$15.70M | -$8.40M | -$7.30M |
| Income Before Tax | $258.40M | $248.10M | $260.90M | $258.90M |
| Income Before Tax Ratio | $0.64 | $0.63 | $0.67 | $0.67 |
| Income Tax Expense | $59.10M | $56.60M | $59.60M | $60.10M |
| Net Income | $199.30M | $191.50M | $201.30M | $198.80M |
| Net Income Ratio | $0.50 | $0.48 | $0.52 | $0.51 |
| EPS | $2.11 | $2.00 | $2.07 | $2.01 |
| Diluted EPS | $2.10 | $2.00 | $2.07 | $2.01 |
| Weighted Avg Shares Outstanding | $94.60M | $98.10M | $97.30M | $98.90M |
| Weighted Avg Shares Outstanding (Diluted) | $94.80M | $98.20M | $97.30M | $99.00M |
Financial performance has remained strong, with revenue growing from $387.10M in Q2 2024 to $402.30M in Q1 2025. Gross profit continued to perform well, with margins at 88% in the latest quarter. Operating income reached $271.20M in Q1 2025, holding a steady 67% margin. While R&D and SG&A expenses fluctuated, EBITDA remained robust at $287.60M. Net income rose to $199.30M, keeping EPS at $2.11. With disciplined cost control and operational efficiency, the company supported consistent profitability, reflecting its ability to deliver stable shareholder value.
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan